{"product_id":"cleveland-clinic-cardiovascular-update-2025","title":"Cleveland Clinic Cardiovascular Update 2025","description":"\u003ch3\u003eCleveland Clinic Cardiovascular Update 2025\u003c\/h3\u003e\n\u003cstrong\u003eCleveland Clinic\u003cbr\u003eCardiovascular Update\u003c\/strong\u003e\n\u003cbr\u003e\u003chr align=\"center\" width=\"95%\"\u003e\n\u003ctable cellpadding=\"0\" cellspacing=\"0\"\u003e\n\u003ccolgroup\u003e \u003ccol width=\"787\"\u003e \u003ccol width=\"641\"\u003e\n\u003c\/colgroup\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" colspan=\"2\"\u003e\u003cstrong\u003eSession 1: Prevention and Management of Cardiovascular Risk, Part 1\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"918\"\u003eTools in CVD Prevention and Risk Management: To Test or Not to Test? Lp(a),apoB, Non HDL-C\u003c\/td\u003e\n\u003ctd\u003eDennis Bruemmer, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStatin Initiation for Primary Prevention Among Statin Naïve Adults and Reasons for Nonadherence\u003c\/td\u003e\n\u003ctd\u003eVikas Sunder, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhen Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk\u003c\/td\u003e\n\u003ctd\u003eAshish Sarraju, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManaging Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes: SGLT2i or GLP1RA or Both?\u003c\/td\u003e\n\u003ctd\u003eDennis Bruemmer, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight Loss Pharmacotherapy: Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications\u003c\/td\u003e\n\u003ctd\u003eSteve Nissen, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKeto, Low Carb, Plant Based, IF: Controversies in the Evidence for the “Best “Diet: What is the Evidence and How to Apply in Clinical Practice\u003c\/td\u003e\n\u003ctd\u003eJulia Zumpano, RD, LD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOld and Evolving Strategies for Treatment-Resistant Hypertension\u003c\/td\u003e\n\u003ctd\u003eLuke Laffin, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSocial Determinants of Health and Cardiovascular Disease: Current State and Future Directions\u003c\/td\u003e\n\u003ctd\u003eLee Kirksey, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanel Discussion\/Q\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eSession Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" colspan=\"2\"\u003e\u003cstrong\u003eSession 2: Prevention and Management of Cardiovascular Risk, Part 2\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHormone Therapy and Heart Health: Debunking Myths, Embracing Evidence\u003c\/td\u003e\n\u003ctd width=\"246\"\u003eLuke Laffin, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThe Intersection of Cardiovascular Disease and Chronic Kidney Disease: Strategies for Reducing Cardiovascular Risk\u003c\/td\u003e\n\u003ctd\u003eCrystal Gadegbeku, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWho Should Get a CAC? How Often? How to Use the Results to Assess Risk?\u003c\/td\u003e\n\u003ctd\u003eMilind Desai, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManagement of CV Issues in the Elderly: Geriatric Cardiology\u003c\/td\u003e\n\u003ctd\u003eArdeshir Hashmi, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePopulation Health Management: Interventions to Control Cardiovascular Disease Risk Factors: Current Status\u003c\/td\u003e\n\u003ctd\u003eLeRoi Hicks, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanel Discussion\/Q\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eSession Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" colspan=\"2\"\u003e\u003cstrong\u003eSession 3: Special Populations\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardiac Disease Remains the Leading Cause of Mortality in Women: What are we Doing to Address This?\u003c\/td\u003e\n\u003ctd\u003eVikas Sunder, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health\u003c\/td\u003e\n\u003ctd\u003eDeirdre Mattina, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompetitive Sports Participation in Athletes with Heart Disease: Evaluation and Management\u003c\/td\u003e\n\u003ctd\u003eTamanna Singh, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardio-oncology: Optimizing the Balance Between Cancer Outcomes and Cardiac Success\u003c\/td\u003e\n\u003ctd\u003ePatrick Collier, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanel Discussion\/Q\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eSession Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" colspan=\"2\"\u003e\u003cstrong\u003eSession 4: Essentials of Cardiovascular Disease\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRole of Advanced Imaging for Ischemic Heart Disease: CT, CMR, Nuclear and Advanced Echocardiography\u003c\/td\u003e\n\u003ctd\u003eSaberio Lo Presti Vega, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCreating a Pathway for the Management of Stable Angina in Your Clinic: Structured Risk Assessment and Clinical Decision Making\u003c\/td\u003e\n\u003ctd\u003eBen Alencherry, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eANOCA, INOCA, MINOCA: What Does It All Mean? Diagnostic Testing and Therapeutic Management\u003c\/td\u003e\n\u003ctd\u003eKhalid Ziada, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHow Do I Manage my Post MI Patient (Including DAPT Guidelines\/Duration\/CardiacRehab)\u003c\/td\u003e\n\u003ctd\u003eVenu Menon, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardiac Rehab: Why it is Critical and How Can We Improve Access and Compliance?\u003c\/td\u003e\n\u003ctd\u003eErik Van Iterson, PhD, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeripheral Artery Disease: Assessment and Clinical Decision Making\u003c\/td\u003e\n\u003ctd\u003eLee Kirksey, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanel Discussion\/Q\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eSession Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" colspan=\"2\"\u003e\u003cstrong\u003eSession 5: Structural Heart Disease\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAortic Stenosis: Diagnosis and Management in the Modern Era\u003c\/td\u003e\n\u003ctd\u003eSamir Kapadia, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMR: How to Diagnose and Manage Mitral Valve Disease: When to Refer? What are the Options\u003c\/td\u003e\n\u003ctd width=\"246\"\u003eL. Leonardo Rodriguez, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhat to Know About the Natural History of Tricuspid Regurgitation: Current and Future Management Strategies\u003c\/td\u003e\n\u003ctd\u003eAmar Krishnaswamy, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBicuspid and Aneurysm-Associated Aortic Valve Disease: Timing of Intervention and the Role of Family Screening\u003c\/td\u003e\n\u003ctd\u003eMilind Desai, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGuidelines for Anticoagulation Following Structural Heart Therapies\u003c\/td\u003e\n\u003ctd\u003eGrant Reed, MD, MSc\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHypertrophic Cardiomyopathy: Co-management in the Era of Emerging Precision Therapies\u003c\/td\u003e\n\u003ctd\u003eMilind Desai, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanel Discussion\/Q\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eSession Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" colspan=\"2\"\u003e\u003cstrong\u003eSession 6: Heart Failure\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHeart Failure Stages, Phenotypes and Diagnosis and How to Screen for HF in the Primary Care Setting\u003c\/td\u003e\n\u003ctd\u003eRandall Starling, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHFrEF: Essentials of Guideline Directed Medical Therapy Initiation and Titration\u003c\/td\u003e\n\u003ctd\u003eAmanda Vest, MBBS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManaging Comorbidities in HF: Frailty, Anemia, Sleep Apnea, AF, Obesity\u003c\/td\u003e\n\u003ctd\u003eKarlee Hoffman, DO\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEssentials of Diagnosis and Management for HFpEF\u003c\/td\u003e\n\u003ctd\u003eSanjeeb Bhattacharya, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)\u003c\/td\u003e\n\u003ctd\u003eMazen Hanna, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStrategies to Enhance GDMT Implementation and Adherence\u003c\/td\u003e\n\u003ctd\u003eM. Trejeeve Martyn, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManaging Long Term LVADs and Transplant Recipients in the Community Setting\u003c\/td\u003e\n\u003ctd\u003eIke Okwuosa, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThe Importance of Collaboration Between EP and HF: CRT and Novel Pacing\u003c\/td\u003e\n\u003ctd\u003eNiraj Varma, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanel Discussion\/Q\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eSession Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" colspan=\"2\"\u003e\u003cstrong\u003eSession 7: Heart Rhythm\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnosis and Management of New-Onset Atrial Fibrillation\u003c\/td\u003e\n\u003ctd\u003eMohamed Kanj, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAF and Left Atrial Appendage Closure: Current and Future Directions\u003c\/td\u003e\n\u003ctd\u003eMohamed Kanj, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhat I Need to Know to Evaluate and Manage the Patient With PVCs and SVT\u003c\/td\u003e\n\u003ctd\u003ePasquale Santangeli, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEvaluation and Management of Syncope in the Young Adult\u003c\/td\u003e\n\u003ctd\u003eKenneth Mayuga, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFollow-Up of Pacemakers and ICDs For the Non-Electrophysiologist\u003c\/td\u003e\n\u003ctd\u003eKevin F. Kwaku, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWearables for Arrhythmia Care: Current Challenges and Future Prospects\u003c\/td\u003e\n\u003ctd\u003eNiraj Varma, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePanel Discussion\/Q\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eSession Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cp align=\"left\"\u003eEnd\u003c\/p\u003e\n\u003cp align=\"left\"\u003e\u003c\/p\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954449944674,"sku":"MED-AMB03803","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Screenshot-2025-01-29-161041.jpg?v=1779377078","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-cardiovascular-update-2025","provider":"Meducourse","version":"1.0","type":"link"}